Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Proteinase K Market Size Worth $110.43 Million By 2027 | CAGR: 7.6%: Grand View Research, Inc.

This image opens in the lightbox

News provided by

Grand View Research, Inc.

19 Oct, 2020, 08:35 GMT

Share this article

Share toX

Share this article

Share toX

SAN FRANCISCO, Oct. 19, 2020 /PRNewswire/ -- The global proteinase K market is expected to reach USD 110.43 million by 2027, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 7.6% during the forecast period. Proteinase K is a serine protease commonly applied in the digestion of proteins and the removal of contaminants during nucleic acid preparations. The enzyme can deactivate nucleases that can degrade RNA or DNA during the purification and isolation of nucleic acids.

Key suggestions from the report:

  • The infectious disease segment held the largest market share in 2019. The wide adoption of the enzyme in COVID-19 diagnostics is expected to maintain contribute to the dominant share of the segment throughout the forecast period
  • The oncology segment also holds a promising market share in 2019 as the proteinase K enzyme is useful for the analysis of cancer specimens. The enzyme has been used to enhance the extraction of RNA from thyroid fine-needle aspiration biopsy specimens and papillary cancer-derived K1 cells
  • The neurology segment is expected to expand at the fastest CAGR from 2020 to 2027. The wide adoption of proteinase K for the detection of Multiple System Atrophy (MSA), Parkinson's disease, Bovine Spongiform Encephalopathy (BSE) proteins, and other prison-related diseases is attributive for the segment growth
  • Liquid proteinase K is projected to register the highest CAGR throughout the analysis period. Commonly, the liquid formulation of the enzyme is highly resistant to the effects of detergents and chelating agents. The liquid proteinase K is nonspecific in its degrading effects and is very rigorous. Merck KGaA and Carolina Biological Supply Company offer commercial-grade liquid proteases
  • Diagnostic and therapeutic grade enzymes require a high degree of specificity and purity. Therefore, the local manufactures have enhanced their manufacturing and R&D capabilities to provide the highest grade of products
  • The key players in the market are involved in novel product launches, acquisition, collaborations, partnerships, and geographical expansions to reinforce their market presence

Read 120 page research report with ToC on "Proteinase K Market Size, Share & Trends Analysis Report By Therapeutic Area (Neurology, Oncology, Infectious Diseases), By Form (Powder, Liquid), By Region, And Segment Forecasts, 2020 - 2027'' at: https://www.grandviewresearch.com/industry-analysis/proteinase-k-market

Proteinase K also finds applications in pre-hybridization processing during in situ hybridization. It works by surrounding and digesting the target DNA protein which increases the probability of binding of probes to the target nucleic acid. This ultimately helps in the improvement of the hybridization signal.

However, an increase in the enzyme's concentration leads to a subsequent rise in the digestion time. This could lead to damage to the cell structure, shedding of tissue sections, and disappearance of the nucleus as observed during incubation at high temperature. These factors affect the result of hybridization. Therefore, the initial Proteinase K concentration is checked before its use in diagnostic procedures.

Pretreatment with Proteinase K removes the requirement for performing the entire standard protocol for purification and extraction of a COVID-19 sample. The technique has also proved to be efficient and the results produced are as per the standard RT-qPCR method for COVID-19 diagnosis.

North America dominated the overall market in 2019. A well-regulated IVD market coupled with increasing application of molecular IVD techniques is anticipated to positively impact the market growth. Moreover, the local presence of key players that offer diagnostic enzymes is expected to provide growth opportunities to the market. For instance, Creative Enzymes offers a wide range of enzymes that can be used in diagnostics as well as research purposes.

Grand View Research has segmented the global proteinase K market based on therapeutic area, form, and region:

  • Proteinase K Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2027)
    • Infectious Diseases
    • Diabetes
    • Oncology
    • Cardiology
    • Nephrology
    • Autoimmune Diseases
    • Neurology
    • Others
  • Proteinase K Form Outlook (Revenue, USD Million, 2016 - 2027)
    • Powder
    • Liquid
  • Proteinase K Regional Outlook (Revenue, USD Million, 2016 - 2027)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • Middle East and Africa (MEA)
      • South Africa

List of Key Players of the Proteinase K Market

  • Merck KGaA
  • Codexis, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Amano Enzyme Inc.
  • Advanced Enzymes Technologies Ltd.
  • Biocatalysts Ltd.
  • Amicogen
  • Dyadic International
  • BBI Solutions
  • Affymetrix
  • American Laboratories

Find more research reports on Clinical Diagnostics Industry, by Grand View Research:

  • Cervical Dysplasia Market – Global cervical dysplasia market size was valued at USD 509.2 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2020 to 2027.
  • Chemiluminescence Immunoassay Market – Global chemiluminescence immunoassay market size was valued at USD 6.1 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2020 to 2027.
  • D-dimer Testing Market – global D-dimer testing market size was valued at USD 1.2 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.3% from 2020 to 2027.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter 

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg  

Modal title

Also from this source

Modular Construction Market Size to Reach $162.42 Billion by 2030 at CAGR 7.9% - Grand View Research, Inc.

Modular Construction Market Size to Reach $162.42 Billion by 2030 at CAGR 7.9% - Grand View Research, Inc.

The global modular construction market size is estimated to reach USD 162.42 billion by 2030, registering to grow at a CAGR of 7.9% from 2025 to 2030 ...

AI In Diagnostics Market to Hit $5.44 Billion by 2030 at CAGR 22.46% - Grand View Research, Inc.

AI In Diagnostics Market to Hit $5.44 Billion by 2030 at CAGR 22.46% - Grand View Research, Inc.

The global artificial intelligence in diagnostics market size is expected to reach USD 5.44 billion in 2030 and is expected to grow at a CAGR of...

More Releases From This Source

Explore

Biotechnology

Biotechnology

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.